InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Wingrove Theresa, SVP des affaires réglementaires. Officer active across 1 company, notably ImmunoGen, Inc.. Cumulatively, 17 reports have been logged. History available since 30 June 2021. The latest transaction was disclosed on 2 February 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations17 total
21,039 sharesCommon StockSEC:0001104659-24-014705:0
29,640 shares0Common StockSEC:0001415889-24-002872:0
58,900 shares@ US$4.8311.3% of flowCommon StockSEC:0001415889-24-001545:0
615 shares@ US$16.010.4% of flowCommon StockSEC:0001415889-24-000379:0
27,788 shares@ US$4.555.0% of flowCommon StockSEC:0001415889-23-016754:0
6,792 shares@ US$10.652.9% of flowCommon StockSEC:0001415889-23-015711:0
166,725 shares@ US$4.5530.3% of flowCommon StockSEC:0001415889-23-015269:0
19,517 shares@ US$10.658.4% of flowCommon StockSEC:0001415889-23-014917:0
158,641 shares@ US$4.5529.7% of flowCommon StockSEC:0001415889-23-014404:0
50,000 shares@ US$4.5511.6% of flowCommon StockSEC:0001415889-23-013428:0
2,811 shares@ US$4.050.5% of flowCommon StockSEC:0001415889-23-010829:0
1,131 shares@ US$3.920.2% of flowCommon StockSEC:0001415889-23-000106:0
2,645 shares@ US$3.8250.4% of flowCommon StockSEC:0001415889-22-007328:0
2,051 shares@ US$5.600.4% of flowCommon StockSEC:0001179110-22-000104
2,051 shares@ US$5.6027.6% of flowCommon StockSEC:0001179110-22-000104:0
1,768 shares@ US$5.5222.4% of flowCommon StockSEC:0001179110-21-007315:0
1,768 shares@ US$5.520.4% of flowCommon StockSEC:0001179110-21-007315
17 of 17 declarations
About Wingrove Theresa
Theresa Wingrove is the Senior Vice President of Regulatory Affairs at ImmunoGen, Inc. She is responsible for managing regulatory processes, ensuring compliance, and facilitating necessary approvals for the company's products.
